In our analysis, cases with TP53 deletions or mutations exhibited below average AR scores and average AR mRNA levels across multiple cohorts, indicating that loss of TP53 in primary PCa generally leads to decreased AR activity (Figure 2a,b). This evidence concerns the gene TP53 and posterior cortical atrophy.